Together with Consulting Editor Dr. Samir Taneja, Dr. Badrinath
Konety has put together a comprehensive issue that addresses
Salvage therapies for Non-Muscle Invasive Bladder Cancer. Expert
authors have contributed clinical review articles on the following
topics: BCG salvage therapy: Definition and context; Who will
respond to BCG? Predictors and nomograms; Identification of
candidates for salvage therapy: Definition of BCG "Failure";
Predictors of response to Intravesical therapy; Precision medicine
for NMIBC; Salvage therapy using BCG derivatives or single agent
chemotherapy; Intravesical heated Mitomycin: Biology and clinical
utility; Mitomycin derivatives in the salvage setting; Combination
intravesical therapy; Intravesical gene therapy; Immunoncology as
salvage therapy; Role of IDO inhibitors in salvage therapy; and
Novel agents for intravesical therapy. Readers will come away with
the clinical information they need to improve outcomes in patients
with bladder cancer.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!